| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2000;102:1308.)
© 2000 American Heart Association, Inc.
Basic Science Reports |
Ribozyme Oligonucleotides Against Transforming Growth Factor-ß Inhibited Neointimal Formation After Vascular Injury in Rat Model
Potential Application of Ribozyme Strategy to Treat Cardiovascular Disease
From the Department of Geriatric Medicine (K.Y., R.M., N.T., H.N., M.A., J.H., T.O.) and the Division of Gene Therapy Science (R.M., Y.K.), Osaka University Medical School, Suita; BILIS (T.S.), Shiga; and Toyohashi Technology University (A.K.), Toyohashi, Japan.
Correspondence to Ryuichi Morishita, MD, PhD, Associate Professor, Division of Gene Therapy Science, Osaka University Medical School, Suita 565, Japan. E-mail morishit{at}geriat.med.osaka-u.ac.jp
Background—Because the mechanisms of atherosclerosis or restenosis after angioplasty have been postulated to involve an increase in transforming growth factor (TGF)-ß, a selective decrease in TGF-ß may have therapeutic value. Thus, we used the ribozyme strategy to actively cleave the targeted gene to selectively inhibit TGF-ß expression.
Methods and Results—We constructed ribozyme oligonucleotides (ONs) targeted to the sequence of the TGF-ß gene that shows 100% homology among the human, rat, and mouse species. The specificity of ribozyme against TGF-ß gene was confirmed by selective inhibition of TGF-ß mRNA in cultured vascular smooth muscle cells as well as balloon-injured blood vessels in vivo. Importantly, the marked decrease in TGF-ß resulted in significant inhibition of neointimal formation after vascular injury in a rat carotid artery model (P<0.01), whereas DNA-based control ONs and mismatched ribozyme ONs did not have any inhibitory effect on neointimal formation. Inhibition of neointimal formation was accompanied by (1) a reduction in collagen synthesis and mRNA expression of collagen I and III and (2) a significant decrease in DNA synthesis as assessed by proliferating cell nuclear antigen staining. Moreover, we modified ribozyme ONs containing phosphorothioate DNA and RNA targeted to the TGF-ß gene. Of importance, modified ribozyme ONs showed a further reduction in TGF-ß expression.
Conclusions—Overall, this study provides the first evidence that selective blockade of TGF-ß resulted in inhibition of neointimal formation, accompanied by a reduction in collagen synthesis and DNA synthesis in a rat model. We anticipate that modification of ribozyme ON pharmacokinetics will facilitate the potential clinical utility of the ribozyme strategy.
Key Words: atherosclerosis • growth substances • gene therapy • enzymes
This article has been cited by other articles:
 |
|
 |
|
  C. Rodriguez, J. Martinez-Gonzalez, B. Raposo, J. F. Alcudia, A. Guadall, and L. Badimon Regulation of lysyl oxidase in vascular cells: lysyl oxidase as a new player in cardiovascular diseases Cardiovasc Res, July 1, 2008; 79(1): 7 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Khan, A. Agrotis, and A. Bobik Understanding the role of transforming growth factor-{beta}1 in intimal thickening after vascular injury Cardiovasc Res, May 1, 2007; 74(2): 223 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bobik Transforming Growth Factor-{beta}s and Vascular Disorders Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1712 - 1720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wang, J. Zhang, G. Spinetti, L.-Q. Jiang, R. Monticone, D. Zhao, L. Cheng, M. Krawczyk, M. Talan, G. Pintus, et al. Angiotensin II Activates Matrix Metalloproteinase Type II and Mimics Age-Associated Carotid Arterial Remodeling in Young Rats Am. J. Pathol., November 1, 2005; 167(5): 1429 - 1442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kobayashi, K. Yokote, M. Fujimoto, K. Yamashita, A. Sakamoto, M. Kitahara, H. Kawamura, Y. Maezawa, S. Asaumi, T. Tokuhisa, et al. Targeted Disruption of TGF-{beta}-Smad3 Signaling Leads to Enhanced Neointimal Hyperplasia With Diminished Matrix Deposition in Response to Vascular Injury Circ. Res., April 29, 2005; 96(8): 904 - 912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ikeda, Y. Imai, H. Kumagai, T. Nosaka, Y. Morikawa, T. Hisaoka, I. Manabe, K. Maemura, T. Nakaoka, T. Imamura, et al. Vasorin, a transforming growth factor {beta}-binding protein expressed in vascular smooth muscle cells, modulates the arterial response to injury in vivo PNAS, July 20, 2004; 101(29): 10732 - 10737. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-M. Li, L. M. Fan, A. Shah, and G. Brooks Targeting {alpha}v{beta}3 and {alpha}5{beta}1 for gene delivery to proliferating VSMCs: synergistic effect of TGF-{beta}1 Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1123 - H1131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Von der Thusen, J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential Pharmacol. Rev., March 1, 2003; 55(1): 133 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kotani, N. Fukuda, H. Ando, W.-Y. Hu, S. Kunimoto, S. Saito, and K. Kanmatsuse Chimeric DNA-RNA hammerhead ribozyme targeting PDGF A-chain mRNA specifically inhibits neointima formation in rat carotid artery after balloon injury Cardiovasc Res, January 1, 2003; 57(1): 265 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Kintscher, C. Lyon, S. Wakino, D. Bruemmer, X. Feng, S. Goetze, K. Graf, A. Moustakas, B. Staels, E. Fleck, et al. PPAR{alpha} Inhibits TGF-{beta}-Induced {beta}5 Integrin Transcription in Vascular Smooth Muscle Cells by Interacting With Smad4 Circ. Res., November 29, 2002; 91 (11): e35 - e44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. C. Lowe, S. N. Oesterle, and L. M. Khachigian Coronary in-stent restenosis: Current status and future strategies J. Am. Coll. Cardiol., January 16, 2002; 39(2): 183 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Kingston, S. Sinha, A. David, M. G. Castro, P. R. Lowenstein, and A. M. Heagerty Adenovirus-Mediated Gene Transfer of a Secreted Transforming Growth Factor-{beta} Type II Receptor Inhibits Luminal Loss and Constrictive Remodeling After Coronary Angioplasty and Enhances Adventitial Collagen Deposition Circulation, November 20, 2001; 104(21): 2595 - 2601. [Abstract] [Full Text] [PDF]
|
|